Cargando…
Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy
Personalised cancer treatment depends on identification of therapeutically relevant biological subgroups of patients for assessing effect of treatment and to discover new therapeutic options. By analyses in heterogeneous patient populations, the effects may be lost in noise. Squamous cell carcinoma...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540694/ https://www.ncbi.nlm.nih.gov/pubmed/32468587 http://dx.doi.org/10.1002/ijc.33121 |